Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.7K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

875
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
875
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

418
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
418
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

3.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.9K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

2.6K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rethinking Failure to Rescue in Cardiac Surgery.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Genome-wide characterization and cold-responsive expression profile of Rab GTPases and their regulatory proteins in O. rufipogen.

Planta·2026
Same author

A comprehensive evaluation of soil sampling methods: advantages, limitations, and practical implications.

Environmental monitoring and assessment·2026
Same author

Ultrasound-assisted extraction of Ehretia macrophylla wall. Fruit phenolic acids: Process optimization, characterization, and lung protective activities.

Ultrasonics sonochemistry·2026
Same author

Changing Faces: Match Rates and Demographic Shifts in Cardiothoracic Training Programs.

Annals of thoracic surgery short reports·2026
Same author

Mitochondria directly interact with the nuclear pore complex.

Nature·2026
Same journal

A human-specific genetic modifier reconfigures large-scale cortical network dynamics underlying behavioral performance.

bioRxiv : the preprint server for biology·2026
Same journal

<i>Staphylococcus aureus</i> uses a eukaryotic-like uridyltransferase to make UDP-GlcNAc for cell wall synthesis.

bioRxiv : the preprint server for biology·2026
Same journal

Dynamic redistribution of eIF4F controls cap-dependent translation initiation.

bioRxiv : the preprint server for biology·2026
Same journal

When does additional information improve accuracy of RNA secondary structure prediction?

bioRxiv : the preprint server for biology·2026
Same journal

Normative brain-state trajectories reveal deviation from healthy aging in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same journal

Noradrenergic infraslow rhythm during sleep is the critical link between heart-rate dynamics and memory consolidation.

bioRxiv : the preprint server for biology·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

11.9K

Eph-Ephrin Tetramerization Inhibitors Target Bidirectional Signaling to Combat Pain and Addiction.

Hanghang Wang, Amav Khambete, Frances Sprouse

    Biorxiv : the Preprint Server for Biology
    |December 22, 2025
    PubMed
    Summary
    This summary is machine-generated.

    Researchers discovered small molecules that inhibit Eph-Ephrin tetramer formation, targeting EphB1 and EphB2 interactions. These orally available compounds reduce signaling and alleviate pain and withdrawal behaviors, offering a novel therapeutic approach.

    More Related Videos

    Intracranial Pharmacotherapy and Pain Assays in Rodents
    02:26

    Intracranial Pharmacotherapy and Pain Assays in Rodents

    Published on: April 9, 2019

    5.8K
    The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
    07:09

    The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

    Published on: July 16, 2014

    49.2K

    Related Experiment Videos

    Last Updated: Jan 8, 2026

    Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
    09:09

    Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

    Published on: September 20, 2016

    11.9K
    Intracranial Pharmacotherapy and Pain Assays in Rodents
    02:26

    Intracranial Pharmacotherapy and Pain Assays in Rodents

    Published on: April 9, 2019

    5.8K
    The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
    07:09

    The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

    Published on: July 16, 2014

    49.2K

    Area of Science:

    • Molecular Biology
    • Cell Signaling
    • Pharmacology

    Background:

    • Eph receptors and Ephrin ligands are conserved membrane proteins crucial for cell-cell communication.
    • Aberrant Eph/Ephrin signaling is implicated in chronic pain, addiction, cancer, and fibroinflammatory diseases.
    • Bidirectional signaling via Eph/Ephrin interactions plays roles in both development and pathology.

    Purpose of the Study:

    • To identify small molecules that disrupt EphB-EphrinB receptor-ligand interactions.
    • To investigate the therapeutic potential of inhibiting Eph-Ephrin tetramer formation.

    Main Methods:

    • Screening for small molecules targeting Eph-Ephrin interactions.
    • Assessing compound activity against specific EphB-EphrinB interactions (tetramer vs. dimer).
    • Evaluating oral bioavailability, drug-like properties, and in vivo efficacy in pain and withdrawal models.

    Main Results:

    • Discovery of submicromolar compounds specifically inhibiting Eph-Ephrin tetramer formation.
    • Compounds demonstrated efficacy against tetramer-driven EphB1-EphrinB2 and EphB2-EphrinB2 interactions.
    • Orally available inhibitors reduced EphB forward and EphrinB reverse signaling, alleviating inflammatory pain and opioid withdrawal.

    Conclusions:

    • Small molecule inhibitors of Eph-Ephrin tetramer formation represent a novel therapeutic strategy.
    • Targeting these macromolecular interactions can counter pathologies driven by excessive Eph-Ephrin signaling.
    • These findings open new avenues for treating pain, addiction, and cancer.